Bi Asset Management Fondsmaeglerselskab A Edwards Lifesciences Corp Transaction History

Bi Asset Management Fondsmaeglerselskab A

$5.77 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $3.42 Million - $3.82 Million	40,531 Added 122.55%	73,604 $6.8 Million
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $11.8 Million - $15.6 Million	-162,969 Reduced 83.13%	33,073 $3.16 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $1.78 Million - $2.24 Million	28,792 Added 17.21%	196,042 $14.9 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $637,722 - $859,562	-9,205 Reduced 5.22%	167,250 $11.6 Million
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $1.59 Million - $1.85 Million	-19,560 Reduced 9.98%	176,455 $16.6 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $658,908 - $749,857	-8,873 Reduced 4.33%	196,015 $16.2 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $1.6 Million - $2.05 Million	23,423 Added 12.91%	204,888 $15.3 Million
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $215,397 - $280,563	-2,615 Reduced 1.42%	181,465 $15 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $630,066 - $934,318	7,284 Added 4.12%	184,080 $17.5 Million
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $1.53 Million - $1.93 Million	-15,051 Reduced 7.85%	176,796 $20.8 Million
Q4 2021 Feb 02, 2022	SELL	$106.37 - $130.68 $1.27 Million - $1.56 Million	-11,929 Reduced 5.85%	191,847 $24.9 Million
Q3 2021 Nov 09, 2021	SELL	$102.91 - $122.75 $188,119 - $224,387	-1,828 Reduced 0.89%	203,776 $23.1 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $778,957 - $973,325	9,291 Added 4.73%	205,604 $21.3 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $9.73 Million - $11.2 Million	123,660 Added 170.21%	196,313 $16.4 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $763,211 - $971,234	10,646 Added 17.17%	72,653 $6.63 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $899,942 - $1.17 Million	13,394 Added 27.55%	62,007 $4.95 Million
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $1.83 Million - $2.45 Million	31,802 Added 189.17%	48,613 $3.36 Million
Q1 2020 May 11, 2020	BUY	$52.41 - $81.0 $300,676 - $464,697	5,737 Added 51.81%	16,811 $3.17 Million
Q4 2019 Mar 19, 2020	BUY	$71.7 - $82.09 $657,704 - $753,011	9,173 Added 482.54%	11,074 $2.58 Million
Q3 2019 Mar 19, 2020	SELL	$61.55 - $75.43 $14,525 - $17,801	-236 Reduced 11.04%	1,901 $418,000
Q2 2019 Mar 19, 2020	BUY	$55.74 - $64.41 $119,116 - $137,644	2,137 New	2,137 $395,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account